Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis

Can J Cardiol. 2023 Aug;39(8):1152-1153. doi: 10.1016/j.cjca.2022.10.020. Epub 2022 Oct 25.

Authors

Enrica Negro¹, Nathalie Costedoat-Chalumeau², Mariangela Nivuori³, Claudia Gabiati³, Giada Pallini³, Antonio Brucato⁴

Affiliations

¹ Internal Medicine, Ospedale Fatebenefratelli, Milano, Italy. Electronic address: enrica.negro@unimi.it.
² Department of internal medicine, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris University of Paris cité, Paris, France.
³ Internal Medicine, Ospedale Fatebenefratelli, Milano, Italy.
⁴ Università di Milano, Ospedale Fatebenefratelli, Milano, Italy.

PMID: 36306922
DOI: 10.1016/j.cjca.2022.10.020

No abstract available

Publication types

Case Reports

MeSH terms

Antirheumatic Agents* / therapeutic use
Female
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use
Pericarditis* / diagnosis
Pericarditis* / drug therapy
Pregnancy
Recurrence

Substances

Interleukin 1 Receptor Antagonist Protein
Antirheumatic Agents